Cargando…

Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission

BACKGROUND/AIM: Acromegaly is associated with increased morbidity and mortality, mostly due to cardiovascular complications. Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels are associated with coagulation/fibrinolysis and inflammation. Plasma TAFI may play a role in arterial...

Descripción completa

Detalles Bibliográficos
Autores principales:	ERDOĞAN, Mehmet, ÖZBEK, Mustafa, AKBAL, Erdem, ÜRETEN, Kemal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018305/ https://www.ncbi.nlm.nih.gov/pubmed/31549496 http://dx.doi.org/10.3906/sag-1812-231

Ejemplares similares

Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)
por: Valnickova, Zuzana, et al.
Publicado: (2009)

Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
por: Sillen, Machteld, et al.
Publicado: (2021)

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke
por: Kraft, Peter, et al.
Publicado: (2010)

Assessment of thrombin-activatable fibrinolysis inhibitor (TAFI) activation in acquired hemostatic dysfunction: a diagnostic challenge
por: Kim, Hyun Kyung
Publicado: (2010)

Dose-Response Relationship Between Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) and Stroke: A Chinese Case-Control Study
por: Dai, Huixu, et al.
Publicado: (2017)

Elevated levels of activated and inactivated thrombin-activatable fibrinolysis inhibitor in patients with sepsis
por: Park, Rojin, et al.
Publicado: (2010)

Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis
por: Sotos, Katherine E., et al.
Publicado: (2023)

Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
por: Eser, Mehmet, et al.
Publicado: (2012)

Thrombin-activatable fibrinolysis inhibitor and organ dysfunction in disseminated intravascular coagulation associated with sepsis
por: Hayakawa, M, et al.
Publicado: (2011)

Data supporting the structural and functional characterization of Thrombin‐Activatable Fibrinolysis Inhibitor in breast cancer
por: Fawzy, Manal S., et al.
Publicado: (2015)

Thrombin-Activatable Fibrinolysis Inhibitor Polymorphisms and Cerebral Venous Thrombosis in Mexican Mestizo Patients
por: Arauz, Antonio, et al.
Publicado: (2018)

Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study
por: Fawzy, Manal S., et al.
Publicado: (2015)

Thrombin activatable fibrinolysis inhibitor as a bleeding predictor in liver transplantation: a pilot observational study
por: Nedel, Wagner Luis, et al.
Publicado: (2016)

Increased Thrombin-Activatable Fibrinolysis Inhibitor and Decreased Tissue Factor Pathway Inhibitor and Thrombomodulin Levels in Children with Hypothyroidism
por: Alioğlu, Bülent, et al.
Publicado: (2012)

Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor
por: Ito, Yusuke, et al.
Publicado: (2018)

A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor
por: Stanne, Tara M., et al.
Publicado: (2018)

Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes
por: Huang, Qinghua, et al.
Publicado: (2023)

A Case-Control Study of the Dose-Response Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Acute Myocardial Infarction
por: Zhao, Mengnan, et al.
Publicado: (2022)

Isolation, Co-Crystallization and Structure-Based Characterization of Anabaenopeptins as Highly Potent Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa)
por: Schreuder, Herman, et al.
Publicado: (2016)

Relationship Between Polymorphism of Thrombin-Activatable Fibrinolysis Inhibitor Gene +1040C/T and a Cohort of Chinese Women With Recurrent Spontaneous Abortion
por: Fang, Ping, et al.
Publicado: (2021)

Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
por: Bazzi, Zainab A., et al.
Publicado: (2016)

VhH anti‐thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow
por: van Moorsel, Marc V. A., et al.
Publicado: (2022)

Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and Platelets
por: Du, Xiao-Yan, et al.
Publicado: (2009)

Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome
por: Ranucci, Marco, et al.
Publicado: (2020)

Alternative SET/TAFI Promoters Regulate Embryonic Stem Cell Differentiation
por: Edupuganti, Raghu Ram, et al.
Publicado: (2017)

Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2021)

Ratiometric Activatable Cell-Penetrating Peptides Provide Rapid In Vivo Readout of Thrombin Activation**
por: Whitney, Michael, et al.
Publicado: (2013)

Identification of Genes and miRNAs Associated with TAFI-Related Thrombosis: An in Silico Study
por: Rouka, Erasmia, et al.
Publicado: (2023)

Näthähu de ga kähä, de ga t'afi = empáchense de tunas y de miel
por: Bernal Pérez, Filipino
Publicado: (2015)

Large-scale preparation of active caspase-3 in E. coli by designing its thrombin-activatable precursors
por: Kang, Hyo Jin, et al.
Publicado: (2008)

Post-Traumatic Sepsis Is Associated with Increased C5a and Decreased TAFI Levels
por: Vollrath, Jan Tilmann, et al.
Publicado: (2020)

An evaluation of circulating activated TAFI in septic DIC: a case series and review of the literature
por: Totoki, Takaaki, et al.
Publicado: (2022)

Implication of Free Fatty Acids in Thrombin Generation and Fibrinolysis in Vascular Inflammation in Zucker Rats and Evolution with Aging
por: Lagrange, Jérémy, et al.
Publicado: (2017)

MON-310 Factors Associated with Remission After Surgery for Acromegaly
por: Cunha, Clara, et al.
Publicado: (2020)

Low sclerostin levels after long-term remission of acromegaly
por: Claessen, Kim M. J. A., et al.
Publicado: (2021)

Inhibition of plasmin-mediated TAFI activation may affect development but not progression of abdominal aortic aneurysms
por: Bridge, Katherine, et al.
Publicado: (2017)

THU060 Time To First Remission, Medical Therapy And Survival In Acromegaly: UK Acromegaly Register (UKAR) Study
por: Deshmukh, Harshal, et al.
Publicado: (2023)

Association between polymorphisms in the flanking region of the TAFI gene and atherosclerotic cerebral infarction in a Chinese population
por: Li, You, et al.
Publicado: (2014)

Active postoperative acromegaly: sustained remission after discontinuation of somatostatin analogues
por: Alvarez-Escola, Cristina, et al.
Publicado: (2016)

Acromegaly remission, SIADH and pituitary function recovery after macroadenoma apoplexy
por: Sanz-Sapera, E, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ok551qlbtd34471gh38aufmcgt